HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluating the clinical course and prognostic factors of posttransplantation immunoglobulin A nephropathy.

AbstractINTRODUCTION:
Previous reports have suggested that posttransplantation immunoglobulin (Ig) A nephropathy displays a relatively benign course, hardly ever affecting graft function. However, more recent studies with longer follow-up have shown that posttransplantation IgA nephropathy may be a significant contributor to graft loss. Additionally, there may be other clinical or pathological factors that affect long-term graft outcome. We retrospectively analyzed 30 kidney transplant recipients with biopsy-proven IgA nephropathy in their allografts to determine the clinical course and prognostic factors in posttransplantation IgA nephropathy. The median duration of follow-up was 36 months (range, 1 month-17 years). The median onset of IgA nephropathy was 33.6 months posttransplantation (range, 5 days-103 months). The most common presentation was an abnormal urine examination (96.6%). Fifteen (50%) displayed microscopic hematuria with proteinuria more than 1 g/d. Fifteen patients (50%) lost their grafts at a median time of 24 months after the onset of disease (range, 1-93 months). Allograft loss was associated with a high serum creatinine level at the time of diagnosis (3.68 +/- 2.23 vs 1.79 +/- 0.34 mg/dL; P = .006), a greater level of proteinuria at the time of diagnosis (2.43 +/- 0.76 vs 1.29 +/- 1.07 g/d; P = .003), and more than 50% extracapillary proliferation (P = .05). Fibrinoid necrosis on allograft pathology impacted 1-year allograft survival (P = .025).
CONCLUSION:
Posttransplantation IgA nephropathy worsens allograft outcomes among patients with increased serum creatinine level or significant proteinuria at presentation or significant glomerular inflammation and/or tubulointerstitial damage.
AuthorsK Kiattisunthorn, N Premasathian, A Wongwiwatana, P Parichatikanond, B Cheunsuchon, S Vasuvattakul
JournalTransplantation proceedings (Transplant Proc) Vol. 40 Issue 7 Pg. 2349-54 (Sep 2008) ISSN: 0041-1345 [Print] United States
PMID18790233 (Publication Type: Journal Article)
Chemical References
  • HLA Antigens
  • Creatinine
Topics
  • Adult
  • Blood Pressure
  • Cadaver
  • Creatinine (blood)
  • Female
  • Follow-Up Studies
  • Glomerulonephritis, IGA (etiology, physiopathology)
  • HLA Antigens (immunology)
  • Histocompatibility Testing
  • Humans
  • Kidney Transplantation (adverse effects, immunology)
  • Living Donors
  • Male
  • Middle Aged
  • Prognosis
  • Proteinuria (etiology)
  • Retrospective Studies
  • Time Factors
  • Tissue Donors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: